Trial intelligence / Profile preview

Preoperative MRI and SLN Biopsy in Cervical and Endometrial Cancer

NCT05942170Unknown

Sponsor
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Start
Feb 2017
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of indocyanine green in Cervical Cancer (CC) and endometrial cancer (EC), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Sensitivity of preoperative MRI and SLN mapping at 7 days, Specificity of preoperative MRI and SLN mapping at 7 days and 2 more. Status: unknown.

02

Drugs

indocyanine green
03

Conditions

Cervical Cancer (CC)endometrial cancer (EC)

Beyond the preview

Go deeper on NCT05942170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05942170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call